MMS Holdings Executive and Leadership Team

November, 2026

Leadership Overview

MMS Holdings has 5 executives leading key functions including strategy, financial oversight, operational execution, and corporate leadership.

Focused on advancing global clinical research through data-driven innovation, MMS Holdings delivers technology-enabled solutions that accelerate drug development and ensure regulatory compliance for pharmaceutical and biotech partners worldwide.

Leadership Roles at MMS Holdings

  • Chief Executive Officer - Uma Sharma
  • Chief Financial Officer - Stacy Rusley
  • Chief Operating Officer - Abdul Ch
  • President - Micky Miranda
  • President - Yonghoon Jeong
  • Uma Sharma - Chief Executive Officer

    Uma Sharma, the Chief Executive Officer at MMS Holdings, directs the overarching strategic vision for this global data-focused clinical research organization. Sharma architects long-term growth initiatives while overseeing the integration of advanced AI and health data analytics across all service lines. By aligning corporate objectives with the evolving needs of the pharmaceutical and medical device industries, the Chief Executive Officer ensures consistent delivery of high-quality regulatory submissions and biometrics solutions. This leadership role involves fostering a culture of innovation that drives efficiency in drug development processes across North American and international markets. Uma Sharma maintains close collaboration with the board to secure market leadership and client satisfaction. Through rigorous oversight of organizational performance, the Chief Executive Officer sustains the company's reputation for excellence in complex clinical trial execution and strategic consulting, ultimately positioning the firm as a premier partner for global life sciences organizations.

    Stacy Rusley - Chief Financial Officer

    Stacy Rusley, the Chief Financial Officer at MMS Holdings, manages the fiscal health and capital allocation strategies for this technology-enabled clinical research organization. Rusley oversees financial planning, reporting, and risk management frameworks that support the company's global expansion and investment in AI-driven research tools. By optimizing resource distribution across biometrics and regulatory submission departments, the Chief Financial Officer ensures the firm maintains a competitive edge in the pharmaceutical services market. This role involves direct engagement with executive leadership to evaluate the financial viability of new service offerings and international market entries. Stacy Rusley drives fiscal discipline while supporting the infrastructure necessary for high-volume clinical data analytics. Through precise financial modeling and performance analysis, the Chief Financial Officer secures the stability required for long-term growth, enabling the organization to meet the rigorous demands of the biotech and medical device sectors with consistent operational excellence.

    Abdul Ch - Chief Operating Officer

    Abdul Ch, the Chief Operating Officer at MMS Holdings, directs the internal operational workflows and service delivery mechanisms for this global clinical research organization. Ch focuses on scaling the company's biometrics and safety management capabilities to ensure seamless execution of complex clinical trials. By refining operational processes and integrating advanced technology platforms, the Chief Operating Officer enhances the efficiency of regulatory submissions for pharmaceutical and medical device clients. This leadership role involves managing cross-functional teams to maintain high standards of compliance and data integrity across all global projects. Abdul Ch monitors operational metrics to identify opportunities for process improvement and capacity expansion in key regional markets. Through the implementation of standardized operational protocols, the Chief Operating Officer supports the firm's commitment to innovation, ensuring that every clinical research project benefits from optimized workflows and superior data analytics, ultimately driving successful outcomes for the company's diverse client base.

    Micky Miranda - President

    Micky Miranda, the President at MMS Holdings, leads the strategic development and execution of specialized clinical research services for the pharmaceutical and biotech industries. Miranda oversees the expansion of the company's regulatory submission and strategic consulting divisions, ensuring alignment with global industry standards. By fostering strong client relationships and identifying emerging market opportunities, the President drives the adoption of innovative health data analytics solutions. This role involves coordinating with other executive leaders to refine service delivery models that address the unique challenges of drug development and medical device testing. Micky Miranda manages the growth of regional operations, ensuring that the firm maintains its reputation for excellence in complex, data-intensive environments. Through proactive leadership and a focus on client-centric service, the President strengthens the company's market position, facilitating the successful delivery of critical research projects that advance medical science and improve patient outcomes on a global scale.

    Yonghoon Jeong - President

    Yonghoon Jeong, the President at MMS Holdings, directs the technical integration and innovation strategy for the company's clinical research and health data analytics solutions. Jeong focuses on the application of advanced AI and machine learning to enhance trial design and execution, ensuring that the firm remains at the forefront of the CRO industry. By overseeing the development of proprietary technology platforms, the President supports the biometrics and safety management teams in delivering high-precision results for pharmaceutical and medical device clients. This leadership role involves driving digital transformation initiatives that streamline regulatory processes and improve data accuracy. Yonghoon Jeong collaborates with global teams to implement scalable technology solutions that meet the evolving needs of the life sciences sector. Through the continuous refinement of technical capabilities, the President ensures that the organization maintains its competitive advantage, providing clients with the sophisticated tools necessary for efficient, compliant, and successful drug development programs.

    Explore Leadership Teams in Business Services

    Frequently Asked Questions Regarding MMS Holdings Top Executives and Leadership Team

    Who leads MMS Holdings?
    MMS Holdings is led by Uma Sharma (Chief Executive Officer), along with executives such as Stacy Rusley (Chief Financial Officer) and Abdul Ch (Chief Operating Officer).
    Who is part of MMS Holdings’s executive team?
    The executive team of MMS Holdings includes leaders such as Uma Sharma (Chief Executive Officer), Stacy Rusley (Chief Financial Officer), Abdul Ch (Chief Operating Officer) and other senior executives.
    How many executives does MMS Holdings have?
    MMS Holdings has 5 executives leading key business areas.
    What roles are included in MMS Holdings’s leadership team?
    The leadership team of MMS Holdings includes roles such as Chief Executive Officer, Chief Financial Officer, Chief Operating Officer, President, President.